NASDAQ:SNOA Sonoma Pharmaceuticals Q4 2026 Earnings Report $1.22 -0.02 (-1.61%) Closing price 04:00 PM EasternExtended Trading$1.28 +0.06 (+5.33%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Sonoma Pharmaceuticals EPS ResultsActual EPS-$0.33Consensus EPS -$0.24Beat/MissMissed by -$0.09One Year Ago EPSN/ASonoma Pharmaceuticals Revenue ResultsActual Revenue$5.56 millionExpected Revenue$5.57 millionBeat/MissMissed by -$4.00 thousandYoY Revenue GrowthN/ASonoma Pharmaceuticals Announcement DetailsQuarterQ4 2026Date6/16/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsSonoma Pharmaceuticals' next earnings date is estimated for Monday, November 16, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Sonoma Pharmaceuticals Earnings HeadlinesReviewing Sonoma Pharmaceuticals (NASDAQ:SNOA) and Indivior (NASDAQ:INDV)September 25, 2026 | americanbankingnews.comSonoma Pharmaceuticals Cancels Adjourned Special Stockholder MeetingAugust 19, 2026 | tipranks.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 5 at 1:00 AM | Investors Alley (Ad)Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly RevenueAugust 6, 2026 | benzinga.comSonoma Pharmaceuticals Expands At-the-Market Equity Offering CapacityJune 18, 2026 | tipranks.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial ResultsJune 16, 2026 | finanznachrichten.deSee More Sonoma Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sonoma Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sonoma Pharmaceuticals and other key companies, straight to your email. Email Address About Sonoma PharmaceuticalsSonoma Pharmaceuticals (NASDAQ:SNOA) develops and commercializes non-antibiotic, non-steroidal products for wound care, dermatology, eye care, oral care and animal health. Its products are based largely on Microcyn technology, a stabilized hypochlorous-acid formulation designed for use in cleansing, managing and protecting damaged or irritated tissue. The company’s product portfolio has included wound cleansers and gels, dermatological treatments, scar-care products, ophthalmic solutions and veterinary products marketed under brands such as Microcyn, Dermacyn, Celacyn and MicrocynAH. These products are intended for applications including wound management, skin conditions, post-procedure care, eye discomfort and animal wound care. Sonoma Pharmaceuticals sells its products through distributors, commercial partners and other channels in the United States and selected international markets. The company was formerly known as Oculus Innovative Sciences and adopted the Sonoma Pharmaceuticals name in 2016.View Sonoma Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can RunMarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last Longer Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
